Since adenosine-A2A receptor signaling has been linked to TrkB signaling [30], we tested the role of this receptor in AD-induced TrkB response by pharmacologically blocking this receptor before imipramine challenge. This evidence concerns the gene NTRK2 and Alzheimer disease.